glp-1 for ms You might know them as Ozempic, Wegovy, Mounjaro, and Zepbound. receptor agonists are best known managing diabetes and promoting weight loss, but researchers are discovering a wide spectrum of effective The next 40 million GLP-1

The mechanisms underlying headaches associated with weight loss injections are multifactorial and not entirely understood , though several physiological explanations have been proposed

Socially, GLP-1s can be complicated for those struggling with obesity

Their primary mechanisms of action include: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps lower blood sugar levels with a low risk of hypoglycaemia when used alone (though risk increases when combined with insulin or sulfonylureas) Suppressing glucagon release from pancreatic alpha cells, reducing hepatic glucose production Slowing gastric emptying , which prolongs the feeling of fullness after meals Acting on appetite centres in the brain , particularly the hypothalamus, to reduce hunger and food intake These combined effects result in improved glycaemic control for people with diabetes and significant weight loss

Limited insurance coverage and affordability issues create barriers to widespread patient access, particularly in lower-income populations and countries with stringent pricing regulations

Youre stuck choosing between your health and your budgetwhat we call the Quality-Price Gap

Younossi, MD, MPH, shares his insights in a guest editorial